Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Nervous system disorder
Qualitative or quantitative protein defects in neuromuscular diseases
-
Sarcoglycanopathy 3 trials · 10 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan 0 trials · 8 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin 4 trials · 5 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of titin 0 trials · 4 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of tropomyosin 0 trials · 4 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin 0 trials · 3 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of alpha-actin 0 trials · 2 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of nebulin 0 trials · 2 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of myofibrillar proteins 0 trials · 1 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of plectin 0 trials · 1 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of selenoprotein N1 0 trials · 1 incl. sub-types Sub-types →
-
Neuromuscular disease caused by qualitative or quantitative defects of telethonin 0 trials · 1 incl. sub-types Sub-types →
-
Alpha-actinopathy 0 trials Sub-types →
-
Caveolinopathy 0 trials Sub-types →